company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,121719000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,121719000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,49430000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,10659000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,60089000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,61630000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,29677000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,824000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,16188000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,46689000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,14941000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,403000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,40000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-363000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14578000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6565000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8013000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8013000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8013000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27815204.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.29
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28098319.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.29
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27600000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2010.0,Q3,2010-05-01,2010-07-31,2011-09-06 14:06:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.29
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,121659000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,121659000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,53847000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,11007000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,64854000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,56805000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,30760000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,938000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,16390000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48088000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8717000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,345000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,39000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5569000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,5263000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13980000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5994000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7986000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7986000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7986000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27884100.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.29
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28121740.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.28
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27500000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q1,2010-11-01,2011-01-31,2012-03-08 16:01:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.29
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,137658000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,137658000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,60069000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,11950000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,72019000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,65639000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,32873000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,1026000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,18427000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,52326000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13313000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,419000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,39000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1087000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,707000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14020000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6203000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7817000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7817000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7817000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27920233.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.28
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28142176.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.28
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27900000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q2,2011-02-01,2011-04-30,2012-06-08 09:01:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.28
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,148029000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,148029000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,61274000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,13323000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,74597000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,73432000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,33699000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,1007000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,20317000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55023000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,18409000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,459000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,43000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-416000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,17993000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7912000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10081000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10081000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10081000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27941233.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.36
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28147179.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.36
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28000000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q3,2011-05-01,2011-07-31,2012-09-06 09:05:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.36
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,114735000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,114735000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,62769000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,13614000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,76383000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,38352000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34635000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,998000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,-16616000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19017000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,19335000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,524000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6535000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6493000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-482000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18853000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8378000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10475000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10475000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10475000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27971100.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.37
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28207358.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28000000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2011.0,Q4,2011-08-01,2011-10-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.37
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,138793000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,138793000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,65228000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,13448000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,78676000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,60117000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36844000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,843000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,9148000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,46835000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13282000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,358000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,42000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-316000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12966000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,5601000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,7365000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,7365000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,7365000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27887717.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.26
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28041022.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.26
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28300000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q1,2011-11-01,2012-01-31,2013-03-11 12:13:08+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.26
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,151443000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,151443000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,69622000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,14287000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,83909000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,67534000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39772000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,881000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,10110000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,50763000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,16771000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,412000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,0.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,42000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-370000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,16401000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7095000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,9306000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,9306000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,9306000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27684715.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.34
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27877697.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.33
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27400000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q2,2012-02-01,2012-04-30,2013-06-07 16:31:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.34
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,160532000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,160532000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,71763000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,14490000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,86253000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,74279000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39177000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,897000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,11531000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51605000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,22674000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,382000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-151000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,41000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-492000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22182000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9586000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12596000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12596000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12596000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27695215.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.45
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27887765.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.45
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28000000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q3,2012-05-01,2012-07-31,2013-09-06 10:59:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.45
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,163487000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,163487000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,74226000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,14580000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,88806000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,74681000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,39135000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,941000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,11201000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,51277000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,23404000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,303000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-172000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,38000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-437000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22967000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10078000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12889000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12889000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12889000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27742257.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.47
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27920920.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.47
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27700000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2012.0,Q4,2012-08-01,2012-10-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.47
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,161256000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,161256000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,75300000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,15034000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,90334000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,70922000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,41641000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,909000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,12613000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,55163000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,15759000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,300000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-120000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,34000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-386000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15373000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6708000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8665000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8665000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8665000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27716336.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.31
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27912327.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.31
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28000000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q1,2012-11-01,2013-01-31,2014-03-10 17:30:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.31
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,176452000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,176452000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,79368000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,16408000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,95776000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,80676000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43812000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,983000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,15172000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,59967000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,20709000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,434000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-104000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,24000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-514000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20195000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8857000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11338000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11338000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11338000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27698146.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.41
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27879448.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.41
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27700000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q2,2013-02-01,2013-04-30,2014-06-06 11:00:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.41
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,185427000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,185427000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,81321000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,18446000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,99767000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,85660000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,43987000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,1022000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,15592000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,60601000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,25059000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,350000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1046000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,696000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,25755000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11054000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,14701000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,14701000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,14701000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27671880.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27841998.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.53
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27700000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q3,2013-05-01,2013-07-31,2014-09-04 11:01:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,192219000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,192219000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,88232000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,18706000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,106938000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,85281000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,48068000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,1227000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,15540000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,64835000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,20446000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,522000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-210000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,60000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-672000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,19774000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8653000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11121000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11121000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11121000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27690677.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.4
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27851720.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.4
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27800000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2013.0,Q4,2013-08-01,2013-10-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.4
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,181270000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,181270000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,90916000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,18200000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,109116000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,72154000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,49586000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,1114000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,15574000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,66274000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5880000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,609000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-30000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,14000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-625000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5255000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2301000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2954000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2954000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2954000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27700167.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27848492.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,26900000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q1,2013-11-01,2014-01-31,2015-03-09 15:02:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,201366000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,201366000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,94577000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,18240000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,112817000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,88549000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,50992000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,1586000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,17092000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69670000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,18879000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,597000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-44000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-641000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18238000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7965000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10273000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10273000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10273000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27716644.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.37
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27857467.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27800000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q2,2014-02-01,2014-04-30,2015-06-08 21:36:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.37
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,222053000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,222053000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,98904000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,20706000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,119610000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,102443000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,54282000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,1416000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,18874000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,74572000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,27871000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,625000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,90000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,22000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-513000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,27358000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12108000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15250000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15250000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15250000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27721977.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.55
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27864489.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.55
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27700000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q3,2014-05-01,2014-07-31,2014-09-04 11:01:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.55
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,227593000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,227593000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,99612000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,21128000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,120740000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,106853000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,54074000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,1533000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,20451000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,76058000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,30795000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,615000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-143000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,79000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-679000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,30116000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11835000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18281000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18281000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18281000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27716608.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.66
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27855125.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.65
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27700000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2014.0,Q4,2014-08-01,2014-10-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.66
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,208833000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,208833000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,99233000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,19845000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,119078000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,89755000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,58260000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,1567000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,18000000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,77827000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,11928000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,560000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,114000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,22000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-424000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,11504000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4871000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6633000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6633000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6633000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27740309.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27867214.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27600000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q1,2014-11-01,2015-01-31,2015-03-09 15:02:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,223986000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,223986000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,104559000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,totalcostofrevenue,othercostofrevenue,Other Cost of Revenue,+,debit,usd,20444000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,125003000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,98983000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,58797000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,totaloperatingexpenses,depreciationexpense,Depreciation Expense,+,debit,usd,1606000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,19654000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,80057000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,18926000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,666000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,21000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-645000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18281000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7820000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,10461000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,10461000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10461000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27786309.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27881908.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.38
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27500000.0
Bio-Reference Laboratories Inc ,BRLI,,0000792641,2015.0,Q2,2015-02-01,2015-04-30,2015-06-08 21:36:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
